NPPB and pulmonary hypertension: Given the complex etiology and pathophysiology of pulmonary hypertension, a single biomarker (e.g., NTproBNP) can hardly be sufficient to fully reflect the patients’ stages of their disease, disease etiology, clinical prognoses, and risks of death.